Bal Pharma Ltd

NSE: BALPHARMA · BSE: 524824 · Pharmaceuticals & Biotechnology · 32 announcements

Share price: ₹97.50
Market cap: ₹155.2 Cr
Revenue (annual): ₹311.7 Cr
Net profit (annual): ₹6.28 Cr
P/E (TTM): 21.5×Sector 47.4×
Promoter holding: 50.86%+0.00% QoQ
FII holding: 0.15%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 7 Other Announcement 4 Capital Structure Change 3 Management Change 2 Price Movement Clarification 1 Merger & Restructuring 1 Financial Results 1 Dividend 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

7 Sep 2026 18:16 IST BSE

Capital Structure Change

Bal Pharma Capital Structure Change

Bal Pharma Ltd allotted 10,00,000 convertible warrants to its promoter, Mr. Shailesh Siroya, at ₹84 per warrant. This preferential issue aggregates to ₹8.4 Crore.

Value: ₹8.40 Cr

Read the filing ↗

25 Aug 2026 10:48 IST NSE

Capital Structure Change

Bal Pharma Capital Structure Change

Bal Pharma Limited clarified the 18-month tenure for utilizing net proceeds from its preferential warrant allotment. There is no change in the objects of the issue.

Execution: 18 months

Read the filing ↗

10 Aug 2026 16:53 IST BSE

Capital Structure Change

Bal Pharma Capital Structure Change

Bal Pharma's shareholders approved a special resolution via postal ballot to issue 10,00,000 warrants to the promoter on a preferential basis.

Read the filing ↗